Docusate Sodium
- Product NDC
- 0121-0935
- 11-digit product format
- 001210935
- Labeler code
- 0121
- Product ID
- 0121-0935_5cfc4685-c885-4303-a988-5009cbd8e57b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate Sodium
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-08-16
- Substance
- DOCUSATE SODIUM
- Active strength
- 50 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0121-0935 | 0121-0935-16 | D | Discontinued by firm | 2026-10-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 0121-0935 | 0121-0935-16 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Docusate Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F05Q2T2JA0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1245686 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-0935-05 | Docusate Sodium | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 9 | |
| 0121-0935-16 | Docusate Sodium | 473 mL in 1 BOTTLE | LIQUID | 473 | 9 | |
| 0121-0935-40 | Docusate Sodium | 10 in 1 TRAY | LIQUID | 10 | 9 | |
| 0121-0935-40 | Docusate Sodium | 4 in 1 CASE | LIQUID | 4 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-0935-05 | ML - Milliliter | 0121-0935 | bd4be1fb-4d63-4e7c-8bfa-2e34cd4de1c5 | 1 | 2021-10-08 |
| 0121-0935-16 | ML - Milliliter | 0121-0935 | 3bdd2684-e7df-4efc-abb2-b74bbcf7d516 | 1 | 2021-10-08 |
| 0121-0935-40 | ML - Milliliter | 0121-0935 | 3327600b-3340-46f6-b2a4-f6be1a4545bb | 1 | 2021-10-08 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MILK OF MAGNESIA MINT | MAGNESIUM HYDROXIDE | Preferred Pharmaceuticals Inc. | f8bba8cb-a111-4285-8bdb-2273a049c3bb | 2026-07-08 | Warnings | M007 |
| DOCUSATE SODIUM, EXTRA STRENGTH 250 MG | DOCUSATE SODIUM | Advanced Rx LLC | fc8cf24e-8ca1-b3fb-e053-6294a90a7a50 | 2026-07-06 | Warnings | M007 |
| Curewell Docusate Sodium Liquid | DOCUSATE SODIUM.50MG/5ML | RMT HEALTH LLC | 55903043-2a1d-0525-e063-6394a90ae182 | 2026-07-01 | Warnings | M007 |
| Senna | SENNOSIDES 8.6 MG TABLETS | Aarkish Pharmaceuticals NJ Inc. | 564bc9a5-13b5-4cce-a349-6b2e122683ed | 2026-07-01 | Warnings | M007 |
| Senna-S | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | Aarkish Pharmaceuticals NJ Inc. | faca8f3e-d9eb-44c5-93ab-f59ed1c0f56f | 2026-07-01 | Warnings | M007 |
| ENEMEEZ | DOCUSATE SODIUM | Quest Products, LLC | 0b06445d-0839-497e-bdff-e0fe224a7738 | 2026-06-30 | Warnings | M007 |
| ENEMEEZ Plus | DOCUSATE SODIUM AND BENZOCAINE | Quest Products, LLC | 1670ca59-7275-4ac6-bef4-674a7b24c7b3 | 2026-06-30 | Warnings | M007 |
| Mineral oil | MINERAL OIL | CVS Pharmacy, Inc. | 1183bcbc-51ec-e53a-e063-6394a90af0f2 | 2026-06-26 | Warnings, Adverse reactions | M007 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552d9018-cc7d-7e1a-e063-6294a90a3322 | 2026-06-26 | Warnings | M007 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-06-26 | Warnings | M007 |
| Walgreens Gentle Laxative | BISACODYL SUPPOSITORY | Walgreens | 20c43036-830b-0e1d-e063-6394a90adf5f | 2026-06-25 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | be7cab51-ce7e-465d-95db-083e69288cfd | 2026-06-25 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Vi-Jon, LLC | ba490c22-19f0-4887-9509-bd3d32e0f5b1 | 2026-06-24 | Warnings, Adverse reactions | M007 |
| MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | KROGER COMPANY | a1b0c638-6c34-1b72-e053-2995a90acc85 | 2026-06-24 | Warnings | M007 |
| Womens Laxative | WOMENS LAXTIVE | Allegiant Health | 549a11d1-a096-4c22-96b4-2d4f54f46022 | 2026-06-24 | Warnings | M007 |
| Magnesium Citrate | MAGNESIUM CITRATE | Meijer Distribution Inc | f4259fda-19d4-087e-e053-2995a90a7081 | 2026-06-22 | Warnings | M007 |
| STOOL SOFTENER | DOCUSATE SODIUM | Geri-Care Pharmaceuticals, Corp | 3ec42148-6786-22f2-e054-00144ff8d46c | 2026-06-18 | Warnings | M007 |
| Glycerin | GLYCERIN SUPPOSITORY | Everpharm LLC | 546347e5-841e-15ca-e063-6294a90a0c8b | 2026-06-16 | Warnings | M007 |
| Glycerin | GLYCERIN SUPPOSITORY | Everpharm LLC | 5463f869-2b92-4551-e063-6394a90ad6f9 | 2026-06-16 | Warnings | M007 |
| MINICA-S | GLYCERIN | Sato Pharmaceutical Co., Ltd. | 687902eb-e702-4e87-a0ce-9add05e3cbc1 | 2026-06-16 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1245686 | docusate sodium 50 MG in 5 mL Oral Solution | PSN | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 10 MG/ML Oral Solution | SCD | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 10 MG per 1 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 100 MG per 10 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 150 MG per 15 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | DOSS Sodium 10 MG/ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0121-0935-05 | 00121093505 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | ||||
| 0121-0935-16 | 00121093516 | 473 mL in 1 BOTTLE (0121-0935-16) | 473 ml | 2021-08-16 | 0000-00-00 | No | No | Current |
| 0121-0935-40 | 00121093540 | 4 TRAY in 1 CASE (0121-0935-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0935-05) | 4 tray | 2021-08-16 | 0000-00-00 | No | No | Current |